Cadence Pharmaceuticals (CADX) Reports a Q3 Loss
CADX Hot Sheet
Financial Fact:Basic and diluted net loss per share: -0.27
Today's EPS Names:
TARO, BRLI, TLB, More
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reports a Q3 loss of $0.23, 4 cents better than the analyst estimate of ($0.27).
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
